ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026

B LAUSANNE, Switzerland, April 27, 2026 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates…
posteditor
posteditor
Articles: 21727

Other News